Active Sites Display

WP_157729484.1:JDJFOMJM_02017
Sequence length: 1786 aa
5 domain hit(s)
This protein was scanned against CAZyme family profile alignments to identify conserved domains. Each hit below shows a region of the query that aligns to a known CAZyme family. Within each family profile, certain residues are known or predicted to be catalytic — directly involved in the enzyme's chemical reaction. The sequence display compares these critical positions between the query protein and the family consensus:
Match: the query has the expected catalytic residue, suggesting this active site is conserved and likely functional.
Mismatch: the query has a different residue at this position, which may indicate altered activity, a non-functional site, or subfamily variation.
Gap: the catalytic position in the profile has no corresponding residue in the query alignment, suggesting a deletion or truncation in this region.
Match
Mismatch
Gap
Active Site Conservation Analysis
EntryClassNameDomain RangeCoverageConservationCat. SitesMatches
PF01607CBMChitin binding Peritrophin-A domain1–178694.3%44.4%125
PF17786CBMMannosidase Ig/CBM-like domain1–1786100%42.9%102
IPR000974GHGlycoside hydrolase, family 22, lysozyme631–649100%66.7%21
IPR006101GHGlycoside hydrolase, family 21518–1533100%71.4%21
PF03633GHGlycosyl hydrolase family 65, C-terminal domain1719–1786100%62.5%00
Domain coverage (1–1786 aa)
PF01607 — Chitin binding Peritrophin-A domain (domain 1–1786)
Cross-ref: InterPro: IPR002557
GO: GO:0008061 chitin bindingGO:0005576 extracellular region
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 1171 1181 1191 1201 1211 1221 1231 1241 1251 1261 1271 1281 1291 1301 1311 1321 1331 1341 1351 1361 1371 1381 1391 1401 1411 1421 1431 1441 1451 1461 1471 1481 1491 1501 1511 1521 1531 1541 1551 1561 1571 1581 1591 1601 1611 1621 1631 1641 1651 1661 1671 1681 1691 1701 1711 1721 1731 1741 1751 1761 1771 1781 Query: MSRYDRYQSL VELLGHRANE QPERTAYVFL LENGREERCS YGELDAQARG VAANLQQSQH VGERALLLFP PGLDYLYAFF GCLYAGVLPV PAYPPRSNGH FTRLQAIVTD ADATVALTTP AILQEVQSRL SDLPALAGLN WMAPTREAAH ALHSQWQPVP VERESLAFLQ YTSGSTALPK GVMLTHGNLM HNLHLMETKF GTTPDSRCVI WLPPYHDMGL IGGILQPLYT GYPVTLMAPV DFIQKPLRWL ELISKTGATI SGGPNFAYDL CVQKIGPTQR EALDLSSWEV AFSGAEPVRA ATLSRFTQAF APSGFRESAF FPCYGLAEGT LFAAGGHKAI GPVVRSFDAD SLLENQAVVA TEPKEHDRVL VSSGRAKESG QRLAIVDPLS GRSCSDGQVG EIWVSGPSIA KGYWKREEQT ADVFGAKLQG DRVGQDTFLK TGDLGFVLDG ELYVTGRMKD LLILRGRNYY PQDLEQTVQQ SHPAVQNSNG AAVGIEVDGE ERLVIVQEVE RSHRRSNLSE VAELIRKQIS LEHSLQAHAI VLLRPMSIPK TTSGKVQRHA CREQFMNGTL EELFSDVPFA GDEIAMKKSA EPSLHSVNMS REALLALNDS ERQGALEQLL AQLTAAVMRL PLERVQTADG LDVLGLDSLM AAEIKQEVEE RWGVSLPFSR LLSGPTLEEL AVEIGGQLAT CEASLSRQEA AEERLSGDVA LTDGQRALWL MQRLEPQSAA YQIAKAVRVR QELDVEALRV SFRALSKRHP LLRAALEMRD GTPVLFVHEE PLWDVVLEDV AVQEETELHR RLQTAALLPI ASEGEALVRV HLFQKSKHEF VLLLVMHHII CDFWSLGLLL QELTALYGAV RAGTQADLPS PPRSFASFAI EQKRRLDGAR RAELDRFWKQ QLGDDLPVLD LPTDYPRSPV QTFGGRTYTF ALPEADSGRL KDYAKSRGVT MNMLFLAAYQ VLLHRYSGQE TVAVGTPVSG RTGLRDAKTI GYFVNPLVQR ADFDGALTFA DLLAQVREGV TRSLEHQDLP FPLLVDLLQP KRDPAHPPLF QTLFTYQTSP LRDLPGLSGW ALGLDGVEIG GGELAFESVA LPQQFVQFDL ALSAAESGGR FCAVFEYNTA LFLPETIERM ADAYQQLLDA VLEDDQLPVG ALPMQSATAQ ADLLVIGRGP QVGLPRQAGM HERFEHQVQT APERVALVFE DQTYTYGELN ARANRLARHL QRLGVGAGAP VGVCLRRSPE LVTALLAVLK AGGMYVPLDP EYPGERIAYM LADCQAAVLL TSSDLQAELP PYAGTTLCVE EQIDWMTEPE QDLPAVDRQQ AAYLIYTSGS TGRPKGVVVT HHNVTHFYSG MDEQVGCAPT DALLAVTSIC FDISVLELFW TLSCGAKLVL LSEQEAKGTG GGEFSLKRQA QRHGATLLQG TPSLAKLMFS DPETVQALTG LRALLLGGEA LSAKQAAEVR AGLPNVRLFN MYGPTEATVW AVSMEVVDVK GRVPIGRPLA NVRTYVLDDR LQPVPIGVAG ELYLGGDGIA QGYFGRADLT AERFLLDPFA SGGRIYKTGD AVRQLADGTL EFLGRLDHQV KVRGFRIELE EIEAVLLAHP AVQEAVCTAK ESALVAYVVT GRDQELLQPE LLSLLRLKLP AYMVPDHLLF LEALPLTPNG KTDKKALPAP SGDRSRSSAA YVPPATEMER LIVSVWQDVL GTAEVGVDDN FFEVGGNSLK MEQVFSRLQP QLPSVVVITD LFRYPTIRLL AQKLGESADK QQEQAVEAQG RGSARREAMQ KRRGKR Profile: ·········· ···E······ ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ··C···D··· ····T·H··· ·········· ·········· ·········· ·········· ·········· ···C······ ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ··TK······ ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ······C··· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·····C
query > profilegap>C1L14>E15C323>C25A327>D29gap>E30G335>T40H337>H42C394>C44T1203>T55Y1204>K56C1607>C61R1786>C70
PF17786 — Mannosidase Ig/CBM-like domain (domain 1–1786)
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 1171 1181 1191 1201 1211 1221 1231 1241 1251 1261 1271 1281 1291 1301 1311 1321 1331 1341 1351 1361 1371 1381 1391 1401 1411 1421 1431 1441 1451 1461 1471 1481 1491 1501 1511 1521 1531 1541 1551 1561 1571 1581 1591 1601 1611 1621 1631 1641 1651 1661 1671 1681 1691 1701 1711 1721 1731 1741 1751 1761 1771 1781 Query: MSRYDRYQSL VELLGHRANE QPERTAYVFL LENGREERCS YGELDAQARG VAANLQQSQH VGERALLLFP PGLDYLYAFF GCLYAGVLPV PAYPPRSNGH FTRLQAIVTD ADATVALTTP AILQEVQSRL SDLPALAGLN WMAPTREAAH ALHSQWQPVP VERESLAFLQ YTSGSTALPK GVMLTHGNLM HNLHLMETKF GTTPDSRCVI WLPPYHDMGL IGGILQPLYT GYPVTLMAPV DFIQKPLRWL ELISKTGATI SGGPNFAYDL CVQKIGPTQR EALDLSSWEV AFSGAEPVRA ATLSRFTQAF APSGFRESAF FPCYGLAEGT LFAAGGHKAI GPVVRSFDAD SLLENQAVVA TEPKEHDRVL VSSGRAKESG QRLAIVDPLS GRSCSDGQVG EIWVSGPSIA KGYWKREEQT ADVFGAKLQG DRVGQDTFLK TGDLGFVLDG ELYVTGRMKD LLILRGRNYY PQDLEQTVQQ SHPAVQNSNG AAVGIEVDGE ERLVIVQEVE RSHRRSNLSE VAELIRKQIS LEHSLQAHAI VLLRPMSIPK TTSGKVQRHA CREQFMNGTL EELFSDVPFA GDEIAMKKSA EPSLHSVNMS REALLALNDS ERQGALEQLL AQLTAAVMRL PLERVQTADG LDVLGLDSLM AAEIKQEVEE RWGVSLPFSR LLSGPTLEEL AVEIGGQLAT CEASLSRQEA AEERLSGDVA LTDGQRALWL MQRLEPQSAA YQIAKAVRVR QELDVEALRV SFRALSKRHP LLRAALEMRD GTPVLFVHEE PLWDVVLEDV AVQEETELHR RLQTAALLPI ASEGEALVRV HLFQKSKHEF VLLLVMHHII CDFWSLGLLL QELTALYGAV RAGTQADLPS PPRSFASFAI EQKRRLDGAR RAELDRFWKQ QLGDDLPVLD LPTDYPRSPV QTFGGRTYTF ALPEADSGRL KDYAKSRGVT MNMLFLAAYQ VLLHRYSGQE TVAVGTPVSG RTGLRDAKTI GYFVNPLVQR ADFDGALTFA DLLAQVREGV TRSLEHQDLP FPLLVDLLQP KRDPAHPPLF QTLFTYQTSP LRDLPGLSGW ALGLDGVEIG GGELAFESVA LPQQFVQFDL ALSAAESGGR FCAVFEYNTA LFLPETIERM ADAYQQLLDA VLEDDQLPVG ALPMQSATAQ ADLLVIGRGP QVGLPRQAGM HERFEHQVQT APERVALVFE DQTYTYGELN ARANRLARHL QRLGVGAGAP VGVCLRRSPE LVTALLAVLK AGGMYVPLDP EYPGERIAYM LADCQAAVLL TSSDLQAELP PYAGTTLCVE EQIDWMTEPE QDLPAVDRQQ AAYLIYTSGS TGRPKGVVVT HHNVTHFYSG MDEQVGCAPT DALLAVTSIC FDISVLELFW TLSCGAKLVL LSEQEAKGTG GGEFSLKRQA QRHGATLLQG TPSLAKLMFS DPETVQALTG LRALLLGGEA LSAKQAAEVR AGLPNVRLFN MYGPTEATVW AVSMEVVDVK GRVPIGRPLA NVRTYVLDDR LQPVPIGVAG ELYLGGDGIA QGYFGRADLT AERFLLDPFA SGGRIYKTGD AVRQLADGTL EFLGRLDHQV KVRGFRIELE EIEAVLLAHP AVQEAVCTAK ESALVAYVVT GRDQELLQPE LLSLLRLKLP AYMVPDHLLF LEALPLTPNG KTDKKALPAP SGDRSRSSAA YVPPATEMER LIVSVWQDVL GTAEVGVDDN FFEVGGNSLK MEQVFSRLQP QLPSVVVITD LFRYPTIRLL AQKLGESADK QQEQAVEAQG RGSARREAMQ KRRGKR Profile: T········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ········Y· ·S········ R········· ··T······· ·····K···· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ········C· ·C········ ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· N········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ····K·
query > profileM1>T1L649>Y6A652>S9R661>R18S673>T29G686>K42V1149>C68L1152>C71P1291>N90K1785>K109
IPR000974 — Glycoside hydrolase, family 22, lysozyme (domain 631–649)
Cross-ref: InterPro: IPR000974
GO: GO:0003796 lysozyme activity
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 1171 1181 1191 1201 1211 1221 1231 1241 1251 1261 1271 1281 1291 1301 1311 1321 1331 1341 1351 1361 1371 1381 1391 1401 1411 1421 1431 1441 1451 1461 1471 1481 1491 1501 1511 1521 1531 1541 1551 1561 1571 1581 1591 1601 1611 1621 1631 1641 1651 1661 1671 1681 1691 1701 1711 1721 1731 1741 1751 1761 1771 1781 Query: MSRYDRYQSL VELLGHRANE QPERTAYVFL LENGREERCS YGELDAQARG VAANLQQSQH VGERALLLFP PGLDYLYAFF GCLYAGVLPV PAYPPRSNGH FTRLQAIVTD ADATVALTTP AILQEVQSRL SDLPALAGLN WMAPTREAAH ALHSQWQPVP VERESLAFLQ YTSGSTALPK GVMLTHGNLM HNLHLMETKF GTTPDSRCVI WLPPYHDMGL IGGILQPLYT GYPVTLMAPV DFIQKPLRWL ELISKTGATI SGGPNFAYDL CVQKIGPTQR EALDLSSWEV AFSGAEPVRA ATLSRFTQAF APSGFRESAF FPCYGLAEGT LFAAGGHKAI GPVVRSFDAD SLLENQAVVA TEPKEHDRVL VSSGRAKESG QRLAIVDPLS GRSCSDGQVG EIWVSGPSIA KGYWKREEQT ADVFGAKLQG DRVGQDTFLK TGDLGFVLDG ELYVTGRMKD LLILRGRNYY PQDLEQTVQQ SHPAVQNSNG AAVGIEVDGE ERLVIVQEVE RSHRRSNLSE VAELIRKQIS LEHSLQAHAI VLLRPMSIPK TTSGKVQRHA CREQFMNGTL EELFSDVPFA GDEIAMKKSA EPSLHSVNMS REALLALNDS ERQGALEQLL AQLTAAVMRL PLERVQTADG LDVLGLDSLM AAEIKQEVEE RWGVSLPFSR LLSGPTLEEL AVEIGGQLAT CEASLSRQEA AEERLSGDVA LTDGQRALWL MQRLEPQSAA YQIAKAVRVR QELDVEALRV SFRALSKRHP LLRAALEMRD GTPVLFVHEE PLWDVVLEDV AVQEETELHR RLQTAALLPI ASEGEALVRV HLFQKSKHEF VLLLVMHHII CDFWSLGLLL QELTALYGAV RAGTQADLPS PPRSFASFAI EQKRRLDGAR RAELDRFWKQ QLGDDLPVLD LPTDYPRSPV QTFGGRTYTF ALPEADSGRL KDYAKSRGVT MNMLFLAAYQ VLLHRYSGQE TVAVGTPVSG RTGLRDAKTI GYFVNPLVQR ADFDGALTFA DLLAQVREGV TRSLEHQDLP FPLLVDLLQP KRDPAHPPLF QTLFTYQTSP LRDLPGLSGW ALGLDGVEIG GGELAFESVA LPQQFVQFDL ALSAAESGGR FCAVFEYNTA LFLPETIERM ADAYQQLLDA VLEDDQLPVG ALPMQSATAQ ADLLVIGRGP QVGLPRQAGM HERFEHQVQT APERVALVFE DQTYTYGELN ARANRLARHL QRLGVGAGAP VGVCLRRSPE LVTALLAVLK AGGMYVPLDP EYPGERIAYM LADCQAAVLL TSSDLQAELP PYAGTTLCVE EQIDWMTEPE QDLPAVDRQQ AAYLIYTSGS TGRPKGVVVT HHNVTHFYSG MDEQVGCAPT DALLAVTSIC FDISVLELFW TLSCGAKLVL LSEQEAKGTG GGEFSLKRQA QRHGATLLQG TPSLAKLMFS DPETVQALTG LRALLLGGEA LSAKQAAEVR AGLPNVRLFN MYGPTEATVW AVSMEVVDVK GRVPIGRPLA NVRTYVLDDR LQPVPIGVAG ELYLGGDGIA QGYFGRADLT AERFLLDPFA SGGRIYKTGD AVRQLADGTL EFLGRLDHQV KVRGFRIELE EIEAVLLAHP AVQEAVCTAK ESALVAYVVT GRDQELLQPE LLSLLRLKLP AYMVPDHLLF LEALPLTPNG KTDKKALPAP SGDRSRSSAA YVPPATEMER LIVSVWQDVL GTAEVGVDDN FFEVGGNSLK MEQVFSRLQP QLPSVVVITD LFRYPTIRLL AQKLGESADK QQEQAVEAQG RGSARREAMQ KRRGKR Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ···RC····· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ······
query > profileR634>R4V635>C5
IPR006101 — Glycoside hydrolase, family 2 (domain 1518–1533)
Cross-ref: InterPro: IPR006101
GO: GO:0004553 hydrolase activity, hydrolyzing O-glycosyl compoundsGO:0005975 carbohydrate metabolic process
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 1171 1181 1191 1201 1211 1221 1231 1241 1251 1261 1271 1281 1291 1301 1311 1321 1331 1341 1351 1361 1371 1381 1391 1401 1411 1421 1431 1441 1451 1461 1471 1481 1491 1501 1511 1521 1531 1541 1551 1561 1571 1581 1591 1601 1611 1621 1631 1641 1651 1661 1671 1681 1691 1701 1711 1721 1731 1741 1751 1761 1771 1781 Query: MSRYDRYQSL VELLGHRANE QPERTAYVFL LENGREERCS YGELDAQARG VAANLQQSQH VGERALLLFP PGLDYLYAFF GCLYAGVLPV PAYPPRSNGH FTRLQAIVTD ADATVALTTP AILQEVQSRL SDLPALAGLN WMAPTREAAH ALHSQWQPVP VERESLAFLQ YTSGSTALPK GVMLTHGNLM HNLHLMETKF GTTPDSRCVI WLPPYHDMGL IGGILQPLYT GYPVTLMAPV DFIQKPLRWL ELISKTGATI SGGPNFAYDL CVQKIGPTQR EALDLSSWEV AFSGAEPVRA ATLSRFTQAF APSGFRESAF FPCYGLAEGT LFAAGGHKAI GPVVRSFDAD SLLENQAVVA TEPKEHDRVL VSSGRAKESG QRLAIVDPLS GRSCSDGQVG EIWVSGPSIA KGYWKREEQT ADVFGAKLQG DRVGQDTFLK TGDLGFVLDG ELYVTGRMKD LLILRGRNYY PQDLEQTVQQ SHPAVQNSNG AAVGIEVDGE ERLVIVQEVE RSHRRSNLSE VAELIRKQIS LEHSLQAHAI VLLRPMSIPK TTSGKVQRHA CREQFMNGTL EELFSDVPFA GDEIAMKKSA EPSLHSVNMS REALLALNDS ERQGALEQLL AQLTAAVMRL PLERVQTADG LDVLGLDSLM AAEIKQEVEE RWGVSLPFSR LLSGPTLEEL AVEIGGQLAT CEASLSRQEA AEERLSGDVA LTDGQRALWL MQRLEPQSAA YQIAKAVRVR QELDVEALRV SFRALSKRHP LLRAALEMRD GTPVLFVHEE PLWDVVLEDV AVQEETELHR RLQTAALLPI ASEGEALVRV HLFQKSKHEF VLLLVMHHII CDFWSLGLLL QELTALYGAV RAGTQADLPS PPRSFASFAI EQKRRLDGAR RAELDRFWKQ QLGDDLPVLD LPTDYPRSPV QTFGGRTYTF ALPEADSGRL KDYAKSRGVT MNMLFLAAYQ VLLHRYSGQE TVAVGTPVSG RTGLRDAKTI GYFVNPLVQR ADFDGALTFA DLLAQVREGV TRSLEHQDLP FPLLVDLLQP KRDPAHPPLF QTLFTYQTSP LRDLPGLSGW ALGLDGVEIG GGELAFESVA LPQQFVQFDL ALSAAESGGR FCAVFEYNTA LFLPETIERM ADAYQQLLDA VLEDDQLPVG ALPMQSATAQ ADLLVIGRGP QVGLPRQAGM HERFEHQVQT APERVALVFE DQTYTYGELN ARANRLARHL QRLGVGAGAP VGVCLRRSPE LVTALLAVLK AGGMYVPLDP EYPGERIAYM LADCQAAVLL TSSDLQAELP PYAGTTLCVE EQIDWMTEPE QDLPAVDRQQ AAYLIYTSGS TGRPKGVVVT HHNVTHFYSG MDEQVGCAPT DALLAVTSIC FDISVLELFW TLSCGAKLVL LSEQEAKGTG GGEFSLKRQA QRHGATLLQG TPSLAKLMFS DPETVQALTG LRALLLGGEA LSAKQAAEVR AGLPNVRLFN MYGPTEATVW AVSMEVVDVK GRVPIGRPLA NVRTYVLDDR LQPVPIGVAG ELYLGGDGIA QGYFGRADLT AERFLLDPFA SGGRIYKTGD AVRQLADGTL EFLGRLDHQV KVRGFRIELE EIEAVLLAHP AVQEAVCTAK ESALVAYVVT GRDQELLQPE LLSLLRLKLP AYMVPDHLLF LEALPLTPNG KTDKKALPAP SGDRSRSSAA YVPPATEMER LIVSVWQDVL GTAEVGVDDN FFEVGGNSLK MEQVFSRLQP QLPSVVVITD LFRYPTIRLL AQKLGESADK QQEQAVEAQG RGSARREAMQ KRRGKR Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ······N··· ··Y······· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ······
query > profileD1527>N10Y1533>Y16
PF03633 — Glycosyl hydrolase family 65, C-terminal domain (domain 1719–1786)
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171 181 191 201 211 221 231 241 251 261 271 281 291 301 311 321 331 341 351 361 371 381 391 401 411 421 431 441 451 461 471 481 491 501 511 521 531 541 551 561 571 581 591 601 611 621 631 641 651 661 671 681 691 701 711 721 731 741 751 761 771 781 791 801 811 821 831 841 851 861 871 881 891 901 911 921 931 941 951 961 971 981 991 1001 1011 1021 1031 1041 1051 1061 1071 1081 1091 1101 1111 1121 1131 1141 1151 1161 1171 1181 1191 1201 1211 1221 1231 1241 1251 1261 1271 1281 1291 1301 1311 1321 1331 1341 1351 1361 1371 1381 1391 1401 1411 1421 1431 1441 1451 1461 1471 1481 1491 1501 1511 1521 1531 1541 1551 1561 1571 1581 1591 1601 1611 1621 1631 1641 1651 1661 1671 1681 1691 1701 1711 1721 1731 1741 1751 1761 1771 1781 Query: MSRYDRYQSL VELLGHRANE QPERTAYVFL LENGREERCS YGELDAQARG VAANLQQSQH VGERALLLFP PGLDYLYAFF GCLYAGVLPV PAYPPRSNGH FTRLQAIVTD ADATVALTTP AILQEVQSRL SDLPALAGLN WMAPTREAAH ALHSQWQPVP VERESLAFLQ YTSGSTALPK GVMLTHGNLM HNLHLMETKF GTTPDSRCVI WLPPYHDMGL IGGILQPLYT GYPVTLMAPV DFIQKPLRWL ELISKTGATI SGGPNFAYDL CVQKIGPTQR EALDLSSWEV AFSGAEPVRA ATLSRFTQAF APSGFRESAF FPCYGLAEGT LFAAGGHKAI GPVVRSFDAD SLLENQAVVA TEPKEHDRVL VSSGRAKESG QRLAIVDPLS GRSCSDGQVG EIWVSGPSIA KGYWKREEQT ADVFGAKLQG DRVGQDTFLK TGDLGFVLDG ELYVTGRMKD LLILRGRNYY PQDLEQTVQQ SHPAVQNSNG AAVGIEVDGE ERLVIVQEVE RSHRRSNLSE VAELIRKQIS LEHSLQAHAI VLLRPMSIPK TTSGKVQRHA CREQFMNGTL EELFSDVPFA GDEIAMKKSA EPSLHSVNMS REALLALNDS ERQGALEQLL AQLTAAVMRL PLERVQTADG LDVLGLDSLM AAEIKQEVEE RWGVSLPFSR LLSGPTLEEL AVEIGGQLAT CEASLSRQEA AEERLSGDVA LTDGQRALWL MQRLEPQSAA YQIAKAVRVR QELDVEALRV SFRALSKRHP LLRAALEMRD GTPVLFVHEE PLWDVVLEDV AVQEETELHR RLQTAALLPI ASEGEALVRV HLFQKSKHEF VLLLVMHHII CDFWSLGLLL QELTALYGAV RAGTQADLPS PPRSFASFAI EQKRRLDGAR RAELDRFWKQ QLGDDLPVLD LPTDYPRSPV QTFGGRTYTF ALPEADSGRL KDYAKSRGVT MNMLFLAAYQ VLLHRYSGQE TVAVGTPVSG RTGLRDAKTI GYFVNPLVQR ADFDGALTFA DLLAQVREGV TRSLEHQDLP FPLLVDLLQP KRDPAHPPLF QTLFTYQTSP LRDLPGLSGW ALGLDGVEIG GGELAFESVA LPQQFVQFDL ALSAAESGGR FCAVFEYNTA LFLPETIERM ADAYQQLLDA VLEDDQLPVG ALPMQSATAQ ADLLVIGRGP QVGLPRQAGM HERFEHQVQT APERVALVFE DQTYTYGELN ARANRLARHL QRLGVGAGAP VGVCLRRSPE LVTALLAVLK AGGMYVPLDP EYPGERIAYM LADCQAAVLL TSSDLQAELP PYAGTTLCVE EQIDWMTEPE QDLPAVDRQQ AAYLIYTSGS TGRPKGVVVT HHNVTHFYSG MDEQVGCAPT DALLAVTSIC FDISVLELFW TLSCGAKLVL LSEQEAKGTG GGEFSLKRQA QRHGATLLQG TPSLAKLMFS DPETVQALTG LRALLLGGEA LSAKQAAEVR AGLPNVRLFN MYGPTEATVW AVSMEVVDVK GRVPIGRPLA NVRTYVLDDR LQPVPIGVAG ELYLGGDGIA QGYFGRADLT AERFLLDPFA SGGRIYKTGD AVRQLADGTL EFLGRLDHQV KVRGFRIELE EIEAVLLAHP AVQEAVCTAK ESALVAYVVT GRDQELLQPE LLSLLRLKLP AYMVPDHLLF LEALPLTPNG KTDKKALPAP SGDRSRSSAA YVPPATEMER LIVSVWQDVL GTAEVGVDDN FFEVGGNSLK MEQVFSRLQP QLPSVVVITD LFRYPTIRLL AQKLGESADK QQEQAVEAQG RGSARREAMQ KRRGKR Profile: ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ·········· ······
query > profile
↑ Top





v1.01 @copyright 2026 UCLA